Last edition
News about "Corona Remedies to Expand Bhayla Manufacturing Cap"
Corona Remedies to Expand Bhayla Manufacturing Capacity by 400 Million Units
Corona Remedies Limited has announced an expansion of manufacturing capacity at its Bhayla formulation facility to support rising demand for its products. The expansion will add 400 million units of tablet and capsule capacity, with 240 million units expected to be available for utilisation.
Corona Remedies To Expand Bhayla Manufacturing Cap | 29/12/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members